Literature DB >> 16043645

Prevalence of cardiovascular disease risk factor clustering among the adult population of China: results from the International Collaborative Study of Cardiovascular Disease in Asia (InterAsia).

Dongfeng Gu1, Anjali Gupta, Paul Muntner, Shengshou Hu, Xiufang Duan, Jichun Chen, Robert F Reynolds, Paul K Whelton, Jiang He.   

Abstract

BACKGROUND: The prevalence of cardiovascular disease (CVD) risk factors has been increasing in China. METHODS AND
RESULTS: We examined the prevalence of CVD risk factor clustering among Chinese adults aged 35 to 74 years with data from the International Collaborative Study of Cardiovascular Disease in Asia (InterAsia), a cross-sectional survey of a nationally representative sample (n=14 690) conducted during 2000 to 2001 and compared these data with those of US adults from the National Health and Nutrition Examination Survey of 1999 to 2000. Overall, 80.5%, 45.9%, and 17.2% of Chinese adults had > or =1, > or =2, and > or =3 modifiable CVD risk factors (dyslipidemia, hypertension, diabetes, cigarette smoking, and overweight), respectively. By comparison, 93.1%, 73.0%, and 35.9% of US adults had > or =1, > or =2, and > or =3 of these risk factors, respectively. In a multivariate model including age, sex, and area of residence, the odds ratio (95% confidence interval [CI]) of having > or =1, > or =2, and > or =3 CVD risk factors versus none of the studied risk factors was 2.61 (95% CI, 2.09 to 3.27), 3.55 (95% CI, 2.77 to 4.54), and 4.97 (95% CI, 3.67 to 6.74), respectively, for Chinese adults 65 to 74 years old versus 35 to 44 years old; 3.65 (95% CI, 3.21 to 4.15), 4.67 (95% CI, 4.06 to 5.38), and 5.60 (95% CI, 4.70 to 6.67), respectively, for men compared with women; 1.18 (95% CI, 1.07 to 1.30), 1.34 (95% CI, 1.21 to 1.50), and 1.84 (95% CI, 1.60 to 2.12), respectively, for urban compared with rural residents; and 1.98 (95% CI, 1.76 to 2.22), 2.75 (95% CI, 2.42 to 3.13), and 4.36 (95% CI, 3.68 to 5.18), respectively, for residents of northern compared with southern China.
CONCLUSIONS: Clustering of CVD risk factors is common in China. Prevention, detection, and treatment of CVD risk factor clustering should be an important component of a national strategy to reduce the increasing burden of CVD in China.

Entities:  

Mesh:

Year:  2005        PMID: 16043645     DOI: 10.1161/CIRCULATIONAHA.104.515072

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  93 in total

1.  Prevalence of metabolic syndrome in rural and urban Chinese population in Qingdao.

Authors:  J Zhao; Z C Pang; L Zhang; W G Gao; S J Wang; F Ning; H R Nan; J Ren; Q Qiao
Journal:  J Endocrinol Invest       Date:  2011-01-26       Impact factor: 4.256

2.  Common variants in TGFBR2 and miR-518 genes are associated with hypertension in the Chinese population.

Authors:  Jinfeng Chen; Xianghai Zhao; Hairu Wang; Yanchun Chen; Wen Wang; Wei Zhou; Xuecai Wang; Junming Tang; Yanping Zhao; Xiangfeng Lu; Shufeng Chen; Laiyuan Wang; Chong Shen; Song Yang
Journal:  Am J Hypertens       Date:  2014-03-31       Impact factor: 2.689

Review 3.  Type 2 diabetes in China: partnerships in education and research to evaluate new antidiabetic treatments.

Authors:  Richard Donnelly; Binhui Wang; Xianqin Qu
Journal:  Br J Clin Pharmacol       Date:  2006-06       Impact factor: 4.335

4.  Resting heart rate and the risk of developing impaired fasting glucose and diabetes: the Kailuan prospective study.

Authors:  Liang Wang; Liufu Cui; Yanxue Wang; Anand Vaidya; Shuohua Chen; Caifeng Zhang; Ying Zhu; Dongqing Li; Frank B Hu; Shouling Wu; Xiang Gao
Journal:  Int J Epidemiol       Date:  2015-05-22       Impact factor: 7.196

5.  White Rice Intake Varies in Its Association with Metabolic Markers of Diabetes and Dyslipidemia Across Region among Chinese Adults.

Authors:  Fei Dong; Annie-Green Howard; Amy H Herring; Barry M Popkin; Penny Gordon-Larsen
Journal:  Ann Nutr Metab       Date:  2015-06-11       Impact factor: 3.374

6.  The expanding burden of cardiometabolic risk in China: the China Health and Nutrition Survey.

Authors:  S Yan; J Li; S Li; B Zhang; S Du; P Gordon-Larsen; L Adair; B Popkin
Journal:  Obes Rev       Date:  2012-06-28       Impact factor: 9.213

7.  β1-adrenoceptor gene Arg389Gly polymorphism and essential hypertension risk in general population: a meta-analysis.

Authors:  Hao Wang; Jielin Liu; Kuo Liu; Ya Liu; Zuoguang Wang; Yuqing Lou; Qiuli Niu; Wei Gu; Lijuan Wang; Mei Li; Xiaoling Zhu; Shaojun Wen
Journal:  Mol Biol Rep       Date:  2013-04-16       Impact factor: 2.316

Review 8.  Risk assessment and aspirin use in Asian and Western populations.

Authors:  Runlin Gao; Xiaoying Li
Journal:  Vasc Health Risk Manag       Date:  2010-10-21

9.  Burden of diabetes in the adult Chinese population: A systematic literature review and future projections.

Authors:  Changyu Pan; Shuhua Shang; Wilhelm Kirch; Martin Thoenes
Journal:  Int J Gen Med       Date:  2010-07-21

10.  The future impact of population growth and aging on coronary heart disease in China: projections from the Coronary Heart Disease Policy Model-China.

Authors:  Andrew Moran; Dong Zhao; Dongfeng Gu; Pamela Coxson; Chung-Shiuan Chen; Jun Cheng; Jing Liu; Jiang He; Lee Goldman
Journal:  BMC Public Health       Date:  2008-11-27       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.